Medical Devices

With upcoming earnings and a key conference, AirSculpt aims to prove its recent turnaround is real. We analyze the signals beyond the numbers.

UFP Technologies posts record profits, but the real story is its strategic pivot—investing heavily in nearshoring and leadership to dominate MedTech's future.

A landmark study on Haemonetics' VASCADE MVP XL system proves it enables same-day discharge for complex heart procedures, a win for patients and hospitals.

A pivotal CMS ruling grants Carlsmed's AI-driven spinal implants a dedicated payment code, unlocking market access and signaling a new era for med-tech.

The German prosthetics giant just built its first US facility from scratch. It’s more than a clinic; it's a bet on transparency, community, and the 2028 Paralympics.

Private equity giant KKR is acquiring medical device maker Integer in a $5.7B deal, signaling a major investment in the future of outsourced MedTech innovation.

A Mobile startup’s fourth patent for a surgical device isn't just an innovation; it's proof that Alabama's strategic investment in tech is building a new economy.

As CapsoVision preps its Q2 report, investors look past the numbers to its AI-driven pipeline, a key test of its strategy to reshape GI diagnostics.

Spineway secures €1.5M in crucial financing amid rising losses, betting on its innovative ESP® disc and surgeon education to finally turn revenue into profit.

A new Premier Inc. designation gives BRIJ Medical vast market access for its hypoallergenic BRIJ-SEAL, signaling a shift in post-operative care standards.

A Pennsylvania clinic's radical 19-day protocol, powered by advanced hyperbaric tech, is showing remarkable results for veterans with TBI and PTSD.

With a lens clinically shown to stop nearsightedness in 9 of 10 kids, HOYA isn't just launching a product; it's making a power play in a blurry market.

With myopia rates soaring, HOYA's MiYOSMART iQ lens enters Canada with unprecedented clinical results, signaling a major strategic shift in pediatric vision care.

As OrthoPediatrics prepares for a key investor conference, the pediatric device specialist must prove its market leadership can translate into sustainable profit.

MIMEDX's $350M Sanara deal creates a surgical powerhouse, combining complementary portfolios to accelerate growth and challenge market leaders in regenerative medicine.

As Hamilton Beach sets its Q2 earnings call, the focus is less on kitchen gadgets and more on its strategic pivot into healthcare and commercial markets.

New data shows 18M+ Americans have Long Covid. With US insurers denying a promising but unproven treatment, many are spending thousands to go abroad.

CorVascular's new DuplexABI, developed with Terason, merges two key vascular tests. Can this workflow innovation overcome complex reimbursement hurdles?

A $3.5M fundraiser is just the start. Northwell's Feinstein Institutes are turning donations into FDA-approved nerve implants that are changing medicine.

With the hire of tech veteran Dr. Julia Albright, QT Imaging signals a bold pivot from medical hardware to a data-driven, AI-powered breast health platform.